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Abstract
Background: This study was carried out to fully investigate the phenolic chemical constituents of Sarcopyramis nepalensis and determine their
α-glucosidase inhibitory activity.
Materials and Methods: S. nepalensis was extracted using the ultrasonic assistant extraction (UAE) method and further fractionated with
petroleum ether (PE), chloroform (CHCl3), ethyl acetate (EtOAc) and n-butanol (n-BuOH), respectively. The active fraction was
chromatographed on AB-8 macroporous resin column, silica gel column, Sephadex LH-20 column, RP-ODS column and semi-preparative HPLC
column. The isolated phenolic constituents were identified by 1H-Nuclear Magnetic Resonance (NMR), 13C-NMR and mass spectral (MS)
analyses and detected their α-glucosidase inhibitory activity by micro-plate.   
Results: Ten phenolic constituents were isolated and identified from the active fraction of S. nepalensis. They were identified as isorhamnetin(1),
quercetin(2), isorhamnetin-3-O-β-D-glucopyranoside(3), isoquercetin (4),
astragalin(5),isorhamnetin-3-O-(6"-p-coumaroyl)-β-D-glucopyranoside(6),isorhamnetin-3-O-(6"-caffeoyl)-β-D-glucopyranoside(7), isoferulic
acid(8) Caffeic acid(9) and ellagic acid(10). All of the phenolic compounds were assayed for their hypoglycemic activity against α-glucosidase in
vitro. Compound 4, 6 and 7 showed promising α-glucosidase inhibitory activity with the IC50 values of 0.69 mg/ml, 0.56 mg/ml, 0.45 mg/ml,
respectively.
Conclusion: Compounds 5-8 were isolated for the first time from S. nepalensis. This is the first report on the characterization of phenolic
compounds and possible utilization of S. nepalensis for therapeutic intervention in type 2 diabetes.
Key words: α-glucosidase inhibitory, Phenolic constituents, Sarcopyramis nepalensis
Introduction
Sarcopyramis nepalensis belongs to the genus of Sarcopyramis, which is comprised of 4 species and 2 varieties in china (Chen 1999). Most
species are medicinal plants used in folk medicine to treat liver and other inflammatory diseases. S. nepalensis showed good hepatoprotective
activities for lowering aminotransferase and curing choleplania and hepatoma (Guo et al. 2012). Phytochemistry studies of the plant revealed that
phenolic acid and flavonoids were (the) major constituents in the plant (Lan 2010; Zhang et al. 2011; Huang et al. 2013; Wei et al. 2014). It is
well known that phenolic acid and flavonoids have showed good hypoglycemic activity in vivo and in vitro (Ranilla et al. 2010; Sharma et al.
2008). However, the hypoglycemic activity of S. nepalensis was not fully illuminated.
    α-glucosidase is a key enzyme hydrolysing dietary carbohydrate into glucose leading to  high blood glucose. So the α-glucosidase inhibitory 
model was frequently used to screen the therapeutic agents for the control of postprandial hyperglycemia arising from use of natural medicinal
plants and isolated compounds(Wan et al. 2012ab). The purpose of this study is to fully elaborate the yeast α-glucosidase inhibitory phenolic 
constituents from S. nepalensis.
Tan et al., Afr J Tradit Complement Altern Med. (2015) 12(3):156-160
http://dx.doi.org/10.4314/ajtcam.v12i3.20
157
Materials and methods
Plant material
The specimen of S. nepalensis was collected from Sanming city, Fujian Province, P.R. China, in May 2012. A voucher specimen (2012R06)
was deposited at the pharmacy of The First College of Clinical Medical Science, China Three Gorges University. The whole parts of S. nepalensis
were dried at 40 °C in an air oven for 48 h and finely powdered.
General experimental procedures
1H and 13C- Nuclear Magnetic Resonance (NMR) data were recorded on a Bruker Avance-600 FT NMR spectrometer with Tetramethylsilane
(TMS) as internal standard. Mass spectral (ESI-MS) data were acquired on a Q-Star Elite (Applied Biosystems MDS, USA) mass spectrometer.
High performance liquid chromatography (HPLC) was performed on a Shimadzu LC-20AT system. Column chromatography was carried with
silica gel (200-300 mesh) was obtained from Qingdao Marine Chemistry Co. Ltd., Qingdao, People′s Republic of China. ODS (50 μm) and 
Sephadex LH-20 (18-110 μm) were obtained from Pharmacia Co (USA). α-glucosidase (yeast, EC 3.2.1.20) powder and 
4-nitrophenyl-α-D-glucopyranoside (pNPG) were purchased from Sigma–Aldrich (USA). 
Extraction and fractionation with organic solvent
The air-dried plant material (4 kg) was ground and extracted exhaustively by UAE with 75% ethanol. The extracts were pooled and
concentrated. A total extract (580 g) were fractionated with petroleum ether, CHCl3, EtOAc and n-BuOH, respectively. Those solvent extracts
were tested for their α-glucosidase inhibitory activity in order to choose the active fraction. The EtOAc fraction showed the best α-glucosidase 
inhibitory activity and further to isolate the active constituents.
Isolation of the active constituents
The EtOAc extract (78 g) was suspended in hot water (1 L) and subjected to AB-8 macroporous adsorption resin column, eluted with
different concentration of ethanol (from 0%, 30%, 50%, 70% to 100%) to obtain 5 fractions. Fraction 4 (4.76 g, eluted with 70% ethanol) was
subjected to a Sephadex LH-20 column (4 × 120 cm) eluted with methanol to give compound 1 (105 mg) and 2 (780 mg). Fraction 3 (13.8 g,
eluted with 50% ethanol) was subjected to Sephadex LH-20 column (5 × 150 cm) to give 6 sub-fractions(Fr.3A-3F); Fr. 3A (2.2 g) was repeatedly
chromatographed on Silica gel (mesh 200-300) and RP-ODS column gradient eluted with MeOH-H2O to give compound 3 (43 mg) and 5 (18 mg);
Fr. 3B (1.9 g) was repeatedly chromatographed on Silica gel (mesh 200-300), RP-ODS column and semi-preparation HPLC to give compound 4
(21 mg), 6 (19 mg) and 7 (13.5 mg). Fraction 2 (31 g, eluted with 30% ethanol) was chromatographed on Sephadex LH-20 column (5 × 150 cm)
and repeatedly RP-ODS column to give compound 8 (18 mg), 9 (69 mg) and 10 (190 mg).
α-glucosidase inhibitory assay 
    α-glucosidase inhibitory activity was determined by  method of literature (Wan et al. 2013). Briefly, a mixture of 50 μL of different 
concentrations of each isolates and 100 μL of 0.1 M phosphate buffer (pH 6.9) containing yeast α-glucosidase solution (1.0 U/ml) was incubated 
in 96 well plates at 25 °C for 10 min. Then 50 μL of 5 mM pNPG solution (dissolve in 0.1 M phosphate buffer) was added to each well. 
Absorbance was recorded immediately at 405 nm. The reaction mixtures were incubated at 25 °C for 5 min and the Absorbance was recorded
immediately at the same wavelength. 50 μL buffer solutions instead of test isolates were used as control. α-glucosidase inhibitory activity, 
expressed as inhibition (%),was calculated as in Eq 1.
control sample
control
ΔAbs - ΔAbs 
inhibition(% ) = 100 ................................................................(1)
ΔAbs 
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Where controlΔAbs is the difference value of the control (absorbance value of control in 5 minutes minus the absorbance value in 0 minute) and
sampleΔAbs is the difference value of the samples (absorbance value of sample in 5 minutes minus the absorbance value in 0 minute).
Statistical analysis
All experiments were performed in triplicate. Statistical analysis of data was by Microsoft Excel XP and the results were given as mean ±
standard deviation (SD). p  0.05 was considered statistically significant difference.
Results and Discussion
Identification of the isolates (Fig. 1) by NMR and ESI-MS
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Figure. 1: Phenolic compounds isolated from S. nepalensis
isorhamnetin(1) obtained as yellow amorphous powder; UV(MeOH)λmax:371, 255 nm; ESI-MS m/z: 315[M-H]－; 1H-NMR (DMSO-d6, 600
MHz) δ: 7.74 (1H, d, J = 2.0 Hz, H-2'), 7.69(1H, dd, J = 2.0, 8.4 Hz, H-6'), 6.94(1H, d, J = 8.4 Hz, H-5'), 6.48(1H, d, J = 2.0 Hz, H-8), 6.19(1H,
d, J = 2.0 Hz, H-6), 3.84(3H, s, OCH3); 13C-NMR(DMSO-d6, 150 MHz) δ: 147.3(C-2), 135.6(C-3), 175.9(C-4), 156.3(C-5), 98.4(C-6),
163.7(C-7), 93.6(C-8), 160.6(C-9), 103.2(C-10), 121.6(C-1'), 115.4(C-2'), 146.5(C-3'), 148.7(C-4'), 111.3(C-5'), 121.4(C-6'), 55.6(OCH3). The
NMR data were consistent with the literature (Liu et al. 2008).
quercetin(2) obtained as yellow amorphous powder; UV(MeOH)λmax:370, 256 nm; ESI-MS m/z: 301[M-H]－; 1H-NMR (DMSO-d6, 600 MHz) δ:
7.68 (1H,d,J = 2.2 Hz, H-2'), 7.54(1H, dd, J = 2.2, 8.4 Hz, H-6′), 6.88(1H, d, J = 8.4 Hz, H-5'), 6.40(1H, d, J = 2.0 Hz, H-8), 6.18(1H, d, J = 2.0
Hz, H-6). The NMR data were consistent with the literature (Yang N et al. 2006).
isorhamnetin-3-O-β-D-glucopyranoside(3) obtained as yellowish amorphous powder; UV(MeOH)λmax:354, 256 nm; ESI-MS m/z: 477[M-H]
－;
1H-NMR(DMSO-d6, 600 MHz) δ: 7.95 (1H, d, J = 2.0 Hz, H-2'), 7.50(1H, dd, J = 2.0, 8.4 Hz, H-6'), 6.92(1H, d, J = 8.4 Hz, H-5'), 6.44(1H, d, J
= 2.0 Hz, H-8), 6.21(1H, d, J = 2.0 Hz, H-6), 5.57(1H, d, J = 7.4 Hz, H-1″), 3.84(3H, s, OCH3); 13C-NMR (DMSO-d6, 150 MHz) δ: 156.3(C-2),
133.4(C-3), 177.2(C-4), 160.8(C-5), 98.3(C-6), 163.8(C-7), 93.6(C-8), 156.6(C-9), 103.3(C-10), 121.5(C-1′), 115.2(C-2′), 146.5(C-3′), 
149.2(C-4′), 111.3(C-5′), 121.8(C-6′), 55.7(OCH3), 100.6(C-1″), 74.3(C-2″), 77.5(C-3″), 70.2(C-4″), 76.3(C-5″), 60.8(C-6″). The NMR data were 
consistent with the literature (Hong et al. 2000).
isoquercetin (4) obtained as yellowish amorphous powder; UV(MeOH)λmax: 356, 258 nm; ESI-MS m/z: 463[M-H]－; 1H-NMR(DMSO-d6, 600
MHz) δ: 7.58(1H, dd, J = 2.2, 9.0 Hz, H-6'), 7.57 (1H, d, J = 2.2 Hz, H-2'), 6.84(1H, d, J = 9.0 Hz, H-5'),6.40(1H, d, J = 2.1 Hz, H-8), 6.19(1H, d,
J = 2.1 Hz, H-6), 5.47(1H, d, J = 7.3 Hz, H-1″); 13C-NMR(DMSO-d6, 150 MHz) δ: 156.3(C-2), 133.2(C-3), 177.3(C-4), 161.1(C-5), 98.7(C-6),
163.9(C-7), 93.5(C-8), 156.1(C-9), 103.8(C-10), 121.2(C-1'), 115.2(C-2'), 145.3(C-3'), 148.6(C-4'), 115.3(C-5'), 121.4(C-6'), 100.7(C-1″), 
74.2(C-2″), 77.5(C-3″), 69.8(C-4″), 76.3(C-5″), 60.9(C-6″). The NMR data were consistent with the literature (Wan et al. 2012a). 
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astragalin(5) obtained as yellowish amorphous powder; UV (MeOH) λmax: 346, 265 nm; ESI-MS m/z: 447[M-H]－; 1H-NMR(DMSO-d6, 600
MHz) δ: 12.62 (1H, s, OH-5), 10.88 (1H, s, OH-7), 8.04 (2H, d, J = 8.8 Hz, H-2',6'), 6.89 (2H, d, J = 8.8 Hz, H-3',5'), 6.44 (1H, d, J = 1.6 Hz,
H-8), 6.21 (1H, d, J = 1.6 Hz, H-6), 5.47 (1H, d, J = 7.6 Hz, glu-H-1"). The NMR data were consistent with the literature (Wan et al. 2011).
isorhamnetin-3-O-(6"-p-coumaroyl)-β-D-glucopyranoside(6) obtained as yellowish amorphous powder; UV(MeOH)λmax: 356, 257 nm;
ESI-MS m/z: 623[M-H]－; 1H-NMR(DMSO-d6, 600 MHz) δ:12.58(1H, s, OH-5), 7.87(1H, d, J = 2.0 Hz, H-2'), 7.52(1H, dd, J = 2.0, 8.4 Hz,
H-6'), 7.36(1H, d, J = 8.6 Hz, H-2"′, H-6"′), 7.34(1H, d, J = 8.6 Hz, H-7"′), 6.90(1H, d , J =8.4Hz, H-5'), 6.78(2H, d, J = 14.5 Hz, H-3"′, H-5"′), 
6.39 (1H, d, J = 2.0 Hz, H-8), 6.16 (1H, d, J = 2.0 Hz, H-6), 6.10(1H, dd, J = 2.1, 15.9 Hz, H-8"′), 3.84(3H, s, OCH3). The NMR data were
consistent with the literature (Karioti et al. 2003).
isorhamnetin-3-O-(6"-caffeoyl)-β-D-glucopyranoside(7) obtained as yellowish amorphous powder; UV(MeOH)λmax:356, 257 nm; ESI-MS
m/z: 639 [M-H]－; 1H-NMR(DMSO-d6, 600 MHz) δ: 12.58(1H, s, OH-5), 7.85(1H, d, J = 2.0 Hz, H-2'), 7.52(1H, dd, J = 2.0, 8.4 Hz, H-6'),
7.28(1H, d, J = 8.6 Hz, H-7"′), 6.96(1H, s, H-2"′), 6.89(1H, d, J =8.4 Hz, H-6"′), 6.78(2H, d, J = 14.5 Hz, H-5"′), 6.75(2H, d, J = 14.5 Hz, H-5'),
6.36(1H, s, J = 2.0 Hz, H-8), 6.14 (1H, d, J =2.0 Hz, H-6), 5.98 (1H, d, J = 15.9 Hz, H-8"′), 5.51(1H, d, J = 7.02 Hz, H-1″), 3.83(3H, s, OCH3).
The NMR data were consistent with the literature (Karioti et al. 2003).
isoferulic acid(8) obtained as white amorphous powder; UV(MeOH)λmax:326 nm; ESI-MS m/z: 193[M-H]－; 1H-NMR(DMSO-d6, 600 MHz) δ: 7.
56 (1H , d, J = 15. 9 Hz, H-7), 6.27(1H, J = 15. 9 Hz, H-8); 6. 80(1H, d, J = 8. 2 Hz, H-5), 6.96(1H, dd, J = 1.8, 8.2 Hz, H-6), 7.06(1H, d, J =1.8
Hz, H-2). The NMR data were consistent with the literature (Lan 2010).
Caffeic acid(9) obtained as white amorphous powder; UV(MeOH)λmax:325 nm; ESI-MS m/z: 179[M-H]－;1H-NMR(DMSO-d6, 600 MHz) δ:
6.17(1H, d, J = 15.9 Hz, H-8), 7.42(1H, d, J = 15. 9 Hz, H-7) , 6.76(1H, d, J = 8.1 Hz, H-5) , 6.96(1H, dd, J = 8.1 Hz, H-6), 7.03(1H, s, H-2),
9.15, 9.55(each 1H, s, OH), 12.08(1H, s, COOH). The NMR data were consistent with the literature (Lan 2010).
Ellagic acid(10) obtained as white amorphous powder; UV(MeOH)λmax:368, 253 nm; ESI-MS m/z: 301[M-H]－; 1H-NMR(DMSO-d6, 600 MHz)
δ: 7.47(s); 13C-NMR (DMSO-d6, 150 MHz) δ: 159.1(C=O), 148.1(C-3, 3'), 139.6(C-5, 5'), 136.3 (C-4, 4'), 112.3(C-6, 6'), 110.1(C-1, 1'),
107.5(C-2, 2'). The NMR data were consistent with the literature (Lan 2010).
α-glucosidase inhibitory activity 
Table 1 shows the α-glucosidase inhibitory activity of the isolates from S. nepalensis. The ethyl acetate soluble fractions showed best α-glucosidase 
inhibitory activity compared with other solvent extracts and the positive control drug, acarbose. Therefore, further isolation was conducted on the
ethyl acetate fraction. The α-glucosidase inhibitory activity of the ten isolates was tested at the original concentration of 2.5 mg/mL. Compound 8
and 9 showed < 50 % inhibition activity (p  0.05), while others showed > 50 %. Hence, all of the compounds except 8 and 9 were further tested
and the IC50 was calculated (Table 1).
Table 1: Yeast α-glucosidase inhibitory activity (mean ± SD, n = 3) of isolates of S. nepalensis
isolates IC50b (mg/mL) isolates IC50 (mg/mL)
1 2.09 ± 0.11 6 0.56 ± 0.08
2 1.59 ± 0.23 7 0.45 ± 0.06
3 1.28 ± 0.15 8 >2.5
4 0.69 ± 0.09 9 >2.5
5 1.42 ± 0.24 10 2.19 ± 0.31
Acarbose a 1.23 ± 0.12
a Positive control; b Isolates showed mg/mL as the unit of IC50.
It was well known that the phenolic constituents maybe responsible for the α-glucosidase inhibitory activity. However, the active constituents 
were unknown. An activity-guided active compounds isolation method was used to study theα-glucosidase inhibitory active compounds in G.
medica previously(Tan et al. 2013). In continuation of our studies on α-glucosidase inhibitory phenolic constituents from natural medicinal plants, 
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we make a fully investigate on the α-glucosidase inhibitory constituents from Sarcopyramis nepalensis. Ethyl acetate extract of S. nepalensis
showed good activity and further isolation was conducted on the ethyl acetate extract. Ten phenolic constituents that include seven flavonols and
three phenolic acids were isolated. Flavonol and its glycosides (1-7) showed good activity, which was in good agreement with our previous reports
that many flavonoids from plants have been reported as α-glucosidase inhibitors (Tan et al. 2013). 
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